Could Daily Zinc Be a Game-Changer for Children With Sickle Cell Anemia? – TIF
Thalassaemia International Federation (TIF) shared a post on LinkedIn:
“New research worth following in sickle cell anaemia
A randomized, double-blind, placebo-controlled clinicaltrial led by the Indiana University School of Medicine, in collaboration with research and clinical partners in Uganda, has reported a striking reduction in infections among young children with sickle cell anaemia.
The study followed 100 children aged 1–5 years in Uganda for six months.
Those who received 20 mg of zinc daily experienced a 38% lower incidence of all-cause infections, including respiratory, gastrointestinal, and bacterial infections, compared with those who received a placebo.
All participants also initiated or continued treatment with hydroxyurea.
The findings, published online in JAMA, point to a potentially affordable and accessible approach that merits further investigation, particularly in settings where infections remain a major cause of illness and mortality among children with sickle cell anaemia.
However, the researchers emphasise that these results come from a small, single-site trial and must be confirmed through larger, multisite studies, including studies involving older children.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution